Cargando…

Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum

BACKGROUND: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bioprocess applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering the production of advanced biopharmaceuticals, a major hindrance...

Descripción completa

Detalles Bibliográficos
Autores principales: de Ruijter, Jorg C., Koskela, Essi V., Frey, Alexander D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878073/
https://www.ncbi.nlm.nih.gov/pubmed/27216259
http://dx.doi.org/10.1186/s12934-016-0488-5
_version_ 1782433505844658176
author de Ruijter, Jorg C.
Koskela, Essi V.
Frey, Alexander D.
author_facet de Ruijter, Jorg C.
Koskela, Essi V.
Frey, Alexander D.
author_sort de Ruijter, Jorg C.
collection PubMed
description BACKGROUND: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bioprocess applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering the production of advanced biopharmaceuticals, a major hindrance lies in the yeast endoplasmic reticulum (ER), as it is not equipped for efficient and large scale folding of complex proteins, such as human antibodies. RESULTS: Following the example of professional secretory cells, we show that inducing an ER expansion in yeast by deleting the lipid-regulator gene OPI1 can improve the secretion capacity of full-length antibodies up to fourfold. Based on wild-type and ER-enlarged yeast strains, we conducted a screening of a folding factor overexpression library to identify proteins and their expression levels that enhance the secretion of antibodies. Out of six genes tested, addition of the peptidyl-prolyl isomerase CPR5 provided the most beneficial effect on specific product yield while PDI1, ERO1, KAR2, LHS1 and SIL1 had a mild or even negative effect to antibody secretion efficiency. Combining genes for ER enhancement did not induce any significant additional effect compared to addition of just one element. By combining the Δopi1 strain, with the enlarged ER, with CPR5 overexpression, we were able to boost the specific antibody product yield by a factor of 10 relative to the non-engineered strain. CONCLUSIONS: Engineering protein folding in vivo is a major task for biopharmaceuticals production in yeast and needs to be optimized at several levels. By rational strain design and high-throughput screening applications we were able to increase the specific secreted antibody yields of S. cerevisiae up to 10-fold, providing a promising strain for further process optimization and platform development for antibody production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0488-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4878073
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48780732016-05-25 Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum de Ruijter, Jorg C. Koskela, Essi V. Frey, Alexander D. Microb Cell Fact Research BACKGROUND: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bioprocess applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering the production of advanced biopharmaceuticals, a major hindrance lies in the yeast endoplasmic reticulum (ER), as it is not equipped for efficient and large scale folding of complex proteins, such as human antibodies. RESULTS: Following the example of professional secretory cells, we show that inducing an ER expansion in yeast by deleting the lipid-regulator gene OPI1 can improve the secretion capacity of full-length antibodies up to fourfold. Based on wild-type and ER-enlarged yeast strains, we conducted a screening of a folding factor overexpression library to identify proteins and their expression levels that enhance the secretion of antibodies. Out of six genes tested, addition of the peptidyl-prolyl isomerase CPR5 provided the most beneficial effect on specific product yield while PDI1, ERO1, KAR2, LHS1 and SIL1 had a mild or even negative effect to antibody secretion efficiency. Combining genes for ER enhancement did not induce any significant additional effect compared to addition of just one element. By combining the Δopi1 strain, with the enlarged ER, with CPR5 overexpression, we were able to boost the specific antibody product yield by a factor of 10 relative to the non-engineered strain. CONCLUSIONS: Engineering protein folding in vivo is a major task for biopharmaceuticals production in yeast and needs to be optimized at several levels. By rational strain design and high-throughput screening applications we were able to increase the specific secreted antibody yields of S. cerevisiae up to 10-fold, providing a promising strain for further process optimization and platform development for antibody production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0488-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-23 /pmc/articles/PMC4878073/ /pubmed/27216259 http://dx.doi.org/10.1186/s12934-016-0488-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
de Ruijter, Jorg C.
Koskela, Essi V.
Frey, Alexander D.
Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
title Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
title_full Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
title_fullStr Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
title_full_unstemmed Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
title_short Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
title_sort enhancing antibody folding and secretion by tailoring the saccharomyces cerevisiae endoplasmic reticulum
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878073/
https://www.ncbi.nlm.nih.gov/pubmed/27216259
http://dx.doi.org/10.1186/s12934-016-0488-5
work_keys_str_mv AT deruijterjorgc enhancingantibodyfoldingandsecretionbytailoringthesaccharomycescerevisiaeendoplasmicreticulum
AT koskelaessiv enhancingantibodyfoldingandsecretionbytailoringthesaccharomycescerevisiaeendoplasmicreticulum
AT freyalexanderd enhancingantibodyfoldingandsecretionbytailoringthesaccharomycescerevisiaeendoplasmicreticulum